MetLife Investment Management’s Legence Corp LGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.92M Buy
34,279
+13,469
+65% +$1.1M 0.01% 927
2026
Q1
$1.17M Buy
20,810
+192
+0.9% +$9.68K 0.01% 1327
2025
Q4
$887K Buy
+20,618
New +$815K ﹤0.01% 1496

Other funds holding LGN

MetLife Investment Management's LGN Position: Q2 2026 in Review

MetLife Investment Management increased its Legence Corp (LGN) stake by 65% in Q2 2026, buying an estimated $1.1M and bringing the position to 34,279 shares worth $2.92M. The position accounts for 0.01% of the portfolio, ranked #927.

MetLife Investment Management first reported a position in LGN in Q4 2025 and has held it in 3 quarters since. 267 funds tracked by Wall St. Rank hold LGN as of Q2 2026.

  • MetLife Investment Management held 34,279 shares of Legence Corp worth $2.92M as of Q2 2026.
  • MetLife Investment Management bought 13,469 Legence Corp shares in Q2 2026, an estimated $1.1M.
  • Legence Corp made up 0.01% of MetLife Investment Management's portfolio in Q2 2026, its #927 holding.
  • MetLife Investment Management first reported a position in Legence Corp in Q4 2025 and has held it in 3 quarters since.
  • 267 funds tracked by Wall St. Rank held Legence Corp as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.